A Trademark

Trademark Overview


On Monday, July 25, 2016, a trademark application was filed for A with the United States Patent and Trademark Office. The USPTO has given the A trademark a serial number of 87114868. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 5, 2024. This trademark is owned by Aurealis Pharma AG. The A trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary preparations, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; sanitary preparations for medical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; dietetic food and substances, namely, fermented milk products, drinks and gum, adapted for medical or veterinary use; dietary supplements for humans and animals; health care products, namely, plasters, materials for dressings, ointments, sprays, injections, human therapeutics, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; disinfectants; preparations for destroying vermin; fungicides and herbicides; pharmaceuticals, biosimilars, medicine, drugs, namely, immunomodulators and anticancer agents, antibodies, antibody fragments, checkpoint inhibitors and checkpoint modifiers, vaccines, for human b...
a

General Information


Serial Number87114868
Word MarkA
Filing DateMonday, July 25, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 5, 2024
Registration Number5357644
Registration DateTuesday, December 19, 2017
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 5, 2017

Trademark Statements


Description of MarkThe mark consists of the letter "a" appearing within a stylized border.
Goods and ServicesPharmaceutical and veterinary preparations, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; sanitary preparations for medical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; dietetic food and substances, namely, fermented milk products, drinks and gum, adapted for medical or veterinary use; dietary supplements for humans and animals; health care products, namely, plasters, materials for dressings, ointments, sprays, injections, human therapeutics, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; disinfectants; preparations for destroying vermin; fungicides and herbicides; pharmaceuticals, biosimilars, medicine, drugs, namely, immunomodulators and anticancer agents, antibodies, antibody fragments, checkpoint inhibitors and checkpoint modifiers, vaccines, for human beings and animals; prokaryotic organisms, namely, genetically modified bacteria, bacteria producing growth factors, antibodies, immunomodulators, anticancer agents, checkpoint inhibitors and checkpoint modifiers and vaccines; medicines for human purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; medicines for veterinary purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; bacteriological preparations for medical and veterinary use, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; biological preparations for medical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; biological preparations for veterinary purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; chemical preparations for medical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; chemical preparations for pharmaceutical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; chemical preparations for veterinary purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; pharmaceutical and veterinary preparations and substances in particular for the treatment of cancer, inflammatory diseases, immune system related diseases, specifically autoimmune disorders, and other conditions which can be treated or ameliorated by antibodies or antibody fragments binding to, activating or blocking of a target antigen or ameliorated by immunomodulating factors, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 5, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAurealis Pharma AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBasel 4058
CH

Party NameAurealis Pharma AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBasel 4058
CH

Party NameAurealis Pharma AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4058
CH

Trademark Events


Event DateEvent Description
Thursday, July 28, 2016NEW APPLICATION ENTERED
Thursday, July 28, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 29, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, November 3, 2016ASSIGNED TO EXAMINER
Thursday, November 10, 2016NON-FINAL ACTION WRITTEN
Thursday, November 10, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 10, 2016NON-FINAL ACTION E-MAILED
Tuesday, May 9, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 9, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 12, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 15, 2017SUSPENSION LETTER WRITTEN
Tuesday, September 5, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, May 15, 2017LETTER OF SUSPENSION E-MAILED
Monday, May 15, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, June 16, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, July 23, 2017ASSIGNED TO LIE
Friday, July 28, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 28, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 28, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 16, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 5, 2017PUBLISHED FOR OPPOSITION
Tuesday, December 19, 2017REGISTERED-PRINCIPAL REGISTER
Monday, December 19, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, July 5, 2024CANCELLED SEC. 8 (6-YR)
Thursday, November 16, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, October 31, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 16, 2017NOTICE OF ALLOWANCE CANCELLED